A clinical‐pathological analysis of hepatitis <scp>B</scp> virus recurrence after liver transplantation in <scp>C</scp>hinese patients

Abstract

LT is an effective treatment for HBV-related end-stage liver disease. The combination of ETV and intramuscular HBIG for HBV recurrence prophylaxis after LT was more effective than LAM, especially in Chinese patients with HBV recurrence risk factors.